United States · Who invested in Vantage Oncology?
Vantage Oncology's investors include New Enterprise Associates, Versant Ventures, Salix Ventures, Conning Capital Partners and Camden Partners.
200520062007
$15MSeries B$23MSeries DUnited States · Series D startup
Who invested in Vantage Oncology
2 rounds we have observed, with the 5 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$38Mraised across 2 rounds since 2004, from 2 sources
$15MSeries B$23MSeries D
- Latest round
- Series D, $23MFeb 2007
- Step-upi
- 1.5×
- Investors
- 5
The funding story
Each circle is a round, placed by date and sized by amount. The line above is the running total.
- First round
- Series B, $15M Jun 2004
- Biggest round
- $23M Series D · Feb 2007
- Between rounds
- 2.7 years from the last two
The rounds
- Feb 2007Series D$23M1 new4 returning
From a historical funding record
- Jun 2004Series B$15M4 new
From a historical funding record
Who was in which round
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Series B2004Series D2007
New Enterprise Associates
Versant VenturesSalix VenturesConning Capital Partners
Camden Partners
New Enterprise AssociatesVersant VenturesSalix VenturesConning Capital PartnersCamden PartnersEveryone who backed them
Salix VenturesGrowth equity2rounds
Conning Capital PartnersGrowth equity2rounds
Missing a round, or an investor who was in one? Tell us.
Quick answers about Vantage Oncology
How much has Vantage Oncology raised?
Vantage Oncology has raised $38M across 2 rounds since 2004.
When did Vantage Oncology last raise?
Vantage Oncology's most recent round was a Series D of $23M in Feb 2007.
What was Vantage Oncology's biggest round?
Its most recent round, $23M in Feb 2007, is also its largest on record.
Who backed Vantage Oncology first?
Vantage Oncology's first round on record, in Jun 2004, was backed by New Enterprise Associates, Versant Ventures and Salix Ventures and 1 others.
What stage is Vantage Oncology at?
Vantage Oncology's latest named round is a Series D, in Feb 2007.
Where is Vantage Oncology based?
Vantage Oncology is based in the United States.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.